Association of a polymorphism in PON-1 gene with steroid-induced osteonecrosis of femoral head in Chinese Han population

Diagnostic Pathology

Weiheng Chen³  Na Lin²  Chao Lu³  Yan Li³  Rongtian Wang³  Yimin Hu¹  Shangzhu Li¹  Xiangying Kong²  Yanqiong Zhang²  Zhiyao Wang³ 

[1] Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300041, China;Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China;Wangjing hospital (Hospital of Orthopedics and Traumatology), China Academy of Chinese Medical Sciences, Beijing 100102, China

关键词: Single nucleotide polymorphism;    Paraoxonase-1;    Steroid-induced osteonecrosis of the femoral head;   

Others  :  803952
DOI  :  10.1186/1746-1596-8-186

 received in 2013-10-15, accepted in 2013-10-29,  发布年份 2013

【 摘 要 】

Background

Treatment with steroids covers a wide spectrum of diseases in clinic. However, some users are suffering from serious side effects of steroid administration, while we enjoy the benefit it brings about. Osteonecrosis of the femoral head (ONFH) is a troublesome one among them. Recent studies have demonstrated that lipid metabolism disorder may play a vital role in pathogenesis of ONFH and mutation of the paraoxonase-1 (PON-1) gene may be involved in the occurrence of this disease. However, the relationship between polymorphisms of PON-1 and ONFH has not been thoroughly studied. The aim of this study was to determine whether PON-1 polymorphisms are associated with steroid-induced ONFH through a cohort study among Chinese Han population.

Methods

This trial applied a case–control scheme to compare the clinical data including PON-1 SNP among 94 patients and 106 control subjects to analyze the association between SNP and risk of steroid-induced ONFH. Time of Flight Mass Spectrometer is utilized for genotyping and the result was analyzed in multivariate analysis models.

Results

According to polymorphism test of rs662, its SNP was significantly associated with the risk of ONFH in overdominant analysis model [P value: 0.022; odds ratio (OR): 0.39]. However, genotype frequencies of rs662 of PON-1 gene between case and control group showed no differences (P > 0.05).

Conclusions

Our data suggest for the first time that SNP (rs662) of the PON-1 gene was associated with the risk of steroid-induced ONFH. In addition, PAI-1 SNPs may play an important role in pathogenesis of ONFH.

Virtual slides

The virtual slide(s) for this article can be found here: http://www.diagnosticphatology.diagnomx.eu/vs/1501829501107336 webcite.

【 授权许可】

   
2013 Wang et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Atsumi T, Kuroki Y: Role of impairment of blood supply of the femoral head in the pathogenesis of idiopathic osteonecrosis. Clin Orthop Relat Res 1992, 277:22-30.
• [2]Assouline-Dayan Y, Chang C, Greenspan A, et al.: Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002, 32(2):94-124.
• [3]Petcu EB, Ivanovski S, Wright RG, et al.: Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect? Diagn Pathol 2012, 7:78. doi: 10.1186/1746-1596-7-78 BioMed Central Full Text
• [4]Iwakiri K, Oda Y, Kaneshiro Y, et al.: Effect of simvastatin on steroid-induced osteonecrosis evidenced by the serum lipid level and hepatic cytochrome P4503A in a rabbit model. J Orthop Sci 2008, 13(5):463-468. doi: 10.1007/s00776-008-1257-z
• [5]Zhang Y, Wang S, Li D, et al.: A systems biology-based classifier for hepatocellular carcinoma diagnosis. PLoS One 2011, 6(7):e22426. doi: 10.1371/journal.pone.0022426
• [6]Fisher DE, Bickel WH: Corticosteroid-induced avascular necrosis: a clinical study of seventy-seven patients. J Bone Joint Surg Am 1971, 53(5):859-873.
• [7]Wang GJ, Dughman SS, Reger SI, et al.: The effect of core decompression on femoral head blood flow in steroid-induced avascular necrosis of the femoral head. J Bone Joint Surg Am 1985, 67(1):121-124.
• [8]Jones JJ: Intravascular coagulation and osteonecrosis. Clin Orthop Relat Res 1992, 277:41-53.
• [9]Wang GJ, Sweet DE, Reger SI, et al.: Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits. J Bone Joint Surg Am 1977, 59(6):729-735.
• [10]Xiao-yan W, Xiao-hong N, Wei-heng C, et al.: Effects of apolipoprotein A1 and B gene polymorphism on avascular necrosis of the femoral head in Chinese population. China journal of orthopaedics and traumatology 2008, 21(2):99-102. doi: 10.3969/j.issn.1003-0034.2008.02.006
• [11]Primo-Parmo SL, Sorenson RC, Teiber J, et al.: The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 1996, 33(3):498-507.
• [12]Mackness B, Durrington PN, Mackness MI: The paraoxonase gene family and coronary heart disease. Curr Opin Lipidol 2002, 13(4):357-362.
• [13]Nassar BA, Darvesh S, Bevin LD, et al.: Relation between butyrylcholinesterase K variant, paraoxonase 1 (PON1) Q and R and apolipoprotein E epsilon 4 genes in early-onset coronary artery disease. Clin Biochem 2002, 35(3):205-209.
• [14]Draganov DI, La Du BN: Pharmacogenetics of paraoxonases: a brief review. Naunyn Schmiedebergs Arch Pharmacol 2004, 369(1):78-88. doi:10.1007/s00210-003-0833-1
• [15]Humbert R, Adler DA, Disteche CM, et al.: The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 1993, 3(1):73-76. doi: 10.1038/ng0193-73
• [16]Obata T, Ito T, Yonemura A, et al.: R192Q paraoxonase gene variant is associated with a change in HDL-cholesterol level during dietary caloric restriction in nondiabetic healthy males. J Atheroscler Thromb 2003, 10(1):57-62.
• [17]Voetsch B, Benke KS, Damasceno BP, et al.: Paraoxonase 192 Gln Arg polymorphism: an independent risk factor for nonfatal arterial ischemic stroke among young adults. Stroke 2002, 33(6):1459-1464.
• [18]Hadjigeorgiou GM, Malizos K, Dardiotis E, et al.: Paraoxonase 1 gene polymorphisms in patients with osteonecrosis of the femoral head with and without cerebral white matter lesions. J Orthop Res 2007, 25(8):1087-1093. doi: 10.1002/jor.20393
• [19]Oinuma K, Harada Y, Nawata Y, et al.: Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment. Ann Rheum Dis 2001, 60(12):1145-1148. doi:10.1136/ard.60.12.1145
• [20]Koo KH, Kim R, Kim YS, et al.: Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment. Clin Rheumatol 2002, 21(4):299-303. doi:10.1007/s100670200078
• [21]Mont MA, Jones LC, Hungerford DS: Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Join t Surg(Am) 2006, 88(5):1117-1132. doi: 10.2106/JBJS.E.01041
• [22]Lawlor DA, Day IN, Gaunt TR, et al.: The association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women’s Heart and Health cohort study and a meta-analysis. BMC Genet 2004, 5:17. doi: 10.1186/1471-2156-5-17
• [23]Wheeler JG, Keavney BD, Watkins H, et al.: Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies. Lancet 2004, 363(9410):689-695. doi: 10.1016/S0140-6736(04)15642-0
• [24]Likidlilid A, Akrawinthawong K, Poldee S, et al.: Paraoxonase 1 polymorphisms as the risk factor of coronary heart disease in a Thai population. Acta Cardiol 2010, 65(6):681-691.
• [25]Liu H, Xia P, Liu M, et al.: PON gene polymorphisms and ischaemic stroke: a systematic review and meta analysis. Int J Stroke 2013, 8(2):111-123. doi: 10.1111/j.1747-4949.2012.00813.x
• [26]Lazaros L, Markoula S, Kyritsis A, et al.: Paraoxonase gene polymorphisms and stroke severity. Eur J Neurol 2010, 17(5):757-759. doi: 10.1111/j.1468-1331.2009.02860.x